Corrigendum to: “Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer” [Gynecol Oncol 131 (2013) 169–173]

✍ Scribed by Anwer, Khursheed; Kelly, F. Joseph; Chu, Christina; Fewell, Jason G.; Lewis, Danny; Alvarez, Ronald D.

• Book ID: 122660344
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 146 KB
• Volume: 134
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2014.04.048